help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0311
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castinetti, F.
Right arrow Articles by Brue, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castinetti, F.
Right arrow Articles by Brue, T.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Endocrine Oncology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 8 4483-4488
Copyright © 2005 by The Endocrine Society

Outcome of Gamma Knife Radiosurgery in 82 Patients with Acromegaly: Correlation with Initial Hypersecretion

Frédéric Castinetti, David Taieb, Jean-Marc Kuhn, Philippe Chanson, Manabu Tamura, Philippe Jaquet, Bernard Conte-Devolx, Jean Régis, Henry Dufour and Thierry Brue

Federation of Endocrinology, Diabetes, Metabolic Diseases and Nutrition (F.C., D.T., P.J., B.C.-D., T.B.), Department of Neurosurgery and Functional Neurosurgery (M.T., J.R., H.D.), and Department of Neurosurgery (H.D.), Hôpital de la Timone, Centre Hospitalier Universitaire de Marseille and Faculté de Médecine, Université de la Méditerranée, 13385 Marseille, France; Department of Endocrinology and Metabolic Diseases (J.-M.K.), Centre Hospitalier Universitaire de Rouen, 76031 Rouen, France; and Department of Endocrinology and Reproductive Diseases (P.C.), Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre and Faculté de Médecine Paris XI, 94270 Le Kremlin Bicêtre, France

Address all correspondence and requests for reprints to: Prof. T. Brue, Department of Endocrinology, Hôpital de la Timone, 264 rue St. Pierre, cedex 5, 13385 Marseille, France. E-mail: thierry.brue{at}mail.ap-hm.fr.

Context: Because surgical and medical therapies of acromegaly all have specific limitations, radiotherapy has been used as an adjunctive strategy. Stereotactic radiosurgery has not yet been widely evaluated.

Objective: The objective was to perform an analysis of long-term hormonal effects and tolerance of gamma knife radiosurgery.

Design: Eighty-two patients were prospectively studied over a decade, with a mean follow-up of 49.5 months.

Setting: All patients were treated at the Department of Functional Neurosurgery of Marseille, France.

Patients: The patients included 82 with active acromegaly, of whom 63 had previous transsphenoidal surgery.

Intervention: Intervention included radiosurgery using the Leksell Gamma Unit B model.

Main Outcome Measures: Remission was diagnosed when mean GH levels were less than 2 ng/ml and IGF-I was normal for age off somatostatin agonists (at least 3 months).

Results: Seventeen percent of the patients were in remission without any treatment. Twenty-three percent previously uncontrolled on somatostatin agonists fulfilled the same criteria after gamma knife while maintained on medical treatment. Initial GH and IGF-I levels off somatostatin agonists were significantly higher in uncured than in remission group (P = 0.01 and 0.047, respectively). Withdrawal of somatostatin agonists at the time of radiosurgery had no incidence on the outcome. No significant difference was found in success rate whether patients had previously been treated or not. Long-term side effects included complete (n = 2) or partial (n = 12) hypopituitarism diagnosed 1–7 yr after gamma knife.

Conclusions: Gamma knife radiosurgery may represent a therapeutic approach in patients with moderate initial or residual GH hypersecretion.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Losa, L. Gioia, P. Picozzi, A. Franzin, M. Valle, M. Giovanelli, and P. Mortini
The Role of Stereotactic Radiotherapy in Patients with Growth Hormone-Secreting Pituitary Adenoma
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2546 - 2552.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E. O. Vik-Mo, M. Oksnes, P.-H. Pedersen, T. Wentzel-Larsen, E. Rodahl, F. Thorsen, T. Schreiner, S. Aanderud, and M. Lund-Johansen
Gamma knife stereotactic radiosurgery for acromegaly
Eur. J. Endocrinol., September 1, 2007; 157(3): 255 - 263.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F Castinetti, M Nagai, H Dufour, J-M Kuhn, I Morange, P Jaquet, B Conte-Devolx, J Regis, and T Brue
Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease
Eur. J. Endocrinol., January 1, 2007; 156(1): 91 - 98.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Melmed
Acromegaly
N. Engl. J. Med., December 14, 2006; 355(24): 2558 - 2573.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. J. Jenkins, P. Bates, M. N. Carson, P. M. Stewart, J. A. H. Wass, and on behalf of the UK National Acromegaly Register S
Conventional Pituitary Irradiation Is Effective in Lowering Serum Growth Hormone and Insulin-Like Growth Factor-I in Patients with Acromegaly
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1239 - 1245.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society